Search
for
Sort by
Research 331–360 of 1000+
- Alopecia Areata Treatment Patterns and Satisfaction: Results of a Real-World Cross-Sectional Survey in Europe
- Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies
- Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata
- Meta-Analysis of Gene Expression Reveals the Core Transcriptomic Profile of Lesional Scalp in Alopecia Areata
- Hair follicle stem cells and the collapse of self-tolerance in alopecia: the interplay of barrier function, the microbiome, and immunity
- Unique Treatment for Alopecia Areata Combining Epinephrine With an Intralesional Steroid
- Tofacitinib for the treatment of alopecia areata and variants in adolescents
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- JAK inhibitors and alopecia areata
- Alopecia Areata Treatment Patterns, Healthcare Resource Utilization, and Comorbidities in the US Population Using Insurance Claims
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- Patient Profile and Treatment Characteristics of Adults and Adolescents Prescribed Ritlecitinib for Alopecia Areata in the USA
- Efficacy and safety of tofacitinib in patients with alopecia areata
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- Ferulic acid promotes hair growth via estrogen receptor alpha activation in cultured human dermal papilla cells
- Treatment Patterns and Health-Related Quality of Life in Patients with Alopecia Areata Stratified by Disease Severity in the USA
- Upadacitinib for the Treatment of Systemic Immune Co-Morbidity in One Case: Alopecia Areata, Vitiligo, Ankylosing Spondylitis, and Allergic Rhinitis-Asthma – Multifaceted Control
- Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review
- Evidence Synthesis Gone Awry: The Perils of Aggregating Ineffective or Unsafe Doses in Alopecia Areata Reviews
- Modern and Promising Strategies for Treatment of Alopecia in the United States: Clinical and Pharmacological, Marketing, Regulatory, SWOT Analysis
- Alopecia Areata Associated with Dupilumab: A Case Report and Literature Review
- Turning JAK STATic, a peek into the future of dermatology therapeutics
- Common Causes of Hair Loss and Their Treatment Options
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Case Report: Compound heterozygous variants in LSS and TSPEAR genes causing hypotrichosis type 14 complicated with ectodermal dysplasia type 14
- Longitudinal clinical course, treatment outcomes, and relapse patterns in alopecia areata: a prospective cohort study
- Treatment of frontal fibrosing alopecia: literature review 2020-2025
- Alopecia areata
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients